Categories
Uncategorized

Voters in U.S Reject Marijuana and Psychedelic Legalization, Sending Clear Message to Lawmakers

Spread the love

January 2, 2025By WRD News Team

10

Voters in U.S Reject Marijuana and Psychedelic Legalization, Sending Clear Message to Lawmakers
Share this post?

FacebookTwitterPinterest

Voters across the United States have decisively rejected a series of ballot measures aiming to legalise marijuana and psychedelics, marking a significant shift in public sentiment. On November 5, states spanning the political spectrum, including Florida, North Dakota, South Dakota, and Massachusetts, voted against these proposals. Florida saw the defeat of marijuana legalisation by four points, despite campaigners investing over $150 million in support. North Dakotans refused legalisation for the third consecutive time, with a five-point margin, while South Dakota declined similar measures by 11 points. Massachusetts voters, heavily outspent by pro-legalisation groups, rejected psychedelic drug legalisation by a commanding 14 points.

This widespread opposition reflects growing concerns over the negative effects of marijuana and psychedelic legalisation. Increased public awareness of marijuana’s dangers, particularly its high THC potency, has likely played a role. Reports of adverse health effects, ranging from cannabis use disorder to severe mental health problems like psychosis, have resonated with voters. Another emerging issue is Cannabinoid Hyperemesis Syndrome, a severe condition causing uncontrollable vomiting among frequent users. Studies indicating that recreational legalisation leads to a 13% increase in youth marijuana use, alongside a faster rise in teen addiction rates, have further alarmed parents and communities. Accessibility and marketing of child-friendly THC products, such as gummies, have also faced heavy criticism.

The failure of legalisation efforts in recent years highlights a turning point for the industry, which once anticipated a widespread cultural normalisation of marijuana and psychedelics. Proponents of legalisation have also failed to address critical issues, such as the surge in the illicit cannabis market in legal states, an uptick in emergency room visits, and negligible benefits for marginalised communities. For example, only 2% of the marijuana industry is represented by Black-owned businesses, further fuelling disappointment.

These results send a clear signal to Congress as lawmakers consider drug policy reform. The push to pass measures such as the SAFE Banking Act, designed to strengthen the cannabis industry, now faces increased scrutiny. Critics argue that such legislation would undermine voter sentiment and intensify the commercialisation of an already controversial sector. Proposals to legalise psychedelics, including their use in therapies, are also being challenged, with opponents highlighting limited scientific support for their safety or efficacy.

The election outcomes underline the growing demand for public health and safety to take precedence over the expansion of drug use. Parliament needs to take notice of this shift in public opinion. It’s time to listen to what people are saying and focus on education, prevention, and evidence-based policies. The priority should be on putting communities and families first, not profits or corporate interests.

Source: The Hill